标题
Targeting Inflammation Driven by HMGB1
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-03-20
DOI
10.3389/fimmu.2020.00484
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway
- (2020) Yongyi Zhai et al. MEDICAL SCIENCE MONITOR
- Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis
- (2019) John D. Lee et al. Journal of Neuroinflammation
- Therapeutic Targeting of High Mobility Group Box-1 in Pulmonary Arterial Hypertension
- (2019) Neil M Goldenberg et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
- (2019) Masahiro Nishibori et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
- (2019) Huan Yang et al. MOLECULAR MEDICINE
- Resveratrol protects against asthma‑induced airway inflammation and remodeling by inhibiting the HMGB1/TLR4/NF‑κB pathway
- (2019) Huanhuan Jiang et al. Experimental and Therapeutic Medicine
- High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain
- (2019) Kazue Hisaoka-Nakashima et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Metformin decreases LPS-induced inflammatory response in rabbit annulus fibrosus stem/progenitor cells by blocking HMGB1 release
- (2019) Yingchao Han et al. Aging-US
- SIRT1-regulated HMGB1 release is partially involved in TLR4 signal transduction: A possible anti-neuroinflammatory mechanism of resveratrol in neonatal hypoxic-ischemic brain injury
- (2019) Kai Le et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms
- (2019) Shuang-feng Zi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure
- (2019) Xinyu Yang et al. IMMUNITY
- Extracellular HMGB1 as a therapeutic target in inflammatory diseases
- (2018) Ulf Andersson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Therapeutic time window of anti-high mobility group box-1 antibody administration in mouse model of spinal cord injury
- (2018) Masahide Nakajo et al. NEUROSCIENCE RESEARCH
- Folic acid derived-P5779 mimetics regulate DAMP-mediated inflammation through disruption of HMGB1:TLR4:MD-2 axes
- (2018) Shan Sun et al. PLoS One
- High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells
- (2018) Ulf Andersson et al. SEMINARS IN IMMUNOLOGY
- Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: Evidence for a neuroimmune crosstalk
- (2018) Fumiko Sekiguchi et al. NEUROPHARMACOLOGY
- The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
- (2018) Meihong Deng et al. IMMUNITY
- Combined effect of anti-high-mobility group box-1 monoclonal antibody and peramivir against influenza A virus-induced pneumonia in mice
- (2018) Kazuki Hatayama et al. JOURNAL OF MEDICAL VIROLOGY
- Anti–High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury
- (2018) Yu Okuma et al. World Neurosurgery
- DNA-Mediated Interferon Signature Induction by SLE Serum Occurs in Monocytes Through Two Pathways: A Mechanism to Inhibit Both Pathways
- (2018) Amit Porat et al. Frontiers in Immunology
- Late Peaks of HMGB1 and Sepsis Outcome
- (2018) Eleni Karakike et al. SHOCK
- Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity
- (2017) Takahiro Horiuchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein–DNA ladders
- (2017) Liudmila Andreeva et al. NATURE
- Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice
- (2017) Li Fu et al. Scientific Reports
- Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats
- (2017) Dengli Wang et al. Scientific Reports
- Redox-dependent regulation of hepatocyte absent in melanoma 2 inflammasome activation in sterile liver injury in mice
- (2016) Qian Sun et al. HEPATOLOGY
- A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice
- (2016) Peter Lundbäck et al. HEPATOLOGY
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Frontline Science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock
- (2016) Murielle Grégoire et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice
- (2016) Fleur Schaper et al. MOLECULAR MEDICINE
- Novel strategies for targeting innate immune responses to influenza
- (2016) K A Shirey et al. Mucosal Immunology
- Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats
- (2016) Takeshi Nishida et al. TOXICOLOGY
- HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4Significance
- (2015) Jingjing Cai et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- MD-2 is required for disulfide HMGB1–dependent TLR4 signaling
- (2015) Huan Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloprotease-9 up-regulation in mice with painful peripheral neuropathy
- (2015) Fang Fang Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Sepsis: a roadmap for future research
- (2015) Jonathan Cohen et al. LANCET INFECTIOUS DISEASES
- Unknown
- (2015) Sergio Valdés-Ferrer et al. MOLECULAR MEDICINE
- Critical role of RAGE and HMGB1 in inflammatory heart disease
- (2015) Anna Bangert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis
- (2014) J Xu et al. CELL DEATH AND DIFFERENTIATION
- Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
- (2014) Ying Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Dexmedetomidine Controls Systemic Cytokine Levels through the Cholinergic Anti-inflammatory Pathway
- (2014) Hui Xiang et al. INFLAMMATION
- HMGB1 in health and disease
- (2014) Rui Kang et al. MOLECULAR ASPECTS OF MEDICINE
- Inflammatory caspases are innate immune receptors for intracellular LPS
- (2014) Jianjin Shi et al. NATURE
- Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis
- (2014) Nilesh M. Agalave et al. PAIN
- Sequestering HMGB1 via DNA-Conjugated Beads Ameliorates Murine Colitis
- (2014) Zhongliang Ju et al. PLoS One
- High-Mobility Group Box 1 Inhibition Alleviates Lupus-Like Disease in BXSB Mice
- (2014) C. Zhang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- High Mobility Group Box–1 Mediates Hyperoxia-Induced Impairment ofPseudomonas aeruginosaClearance and Inflammatory Lung Injury in Mice
- (2013) Vivek S. Patel et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1
- (2013) Yoki Nakamura et al. PLoS One
- Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock
- (2013) J. A. Hagar et al. SCIENCE
- Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
- (2013) N. Kayagaki et al. SCIENCE
- Anti-high mobility group box-1 antibody therapy for traumatic brain injury
- (2012) Yu Okuma et al. ANNALS OF NEUROLOGY
- HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
- (2012) Clarissa Anni Wild et al. INTERNATIONAL IMMUNOLOGY
- Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
- (2012) Emilie Venereau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain
- (2012) Polina Feldman et al. Journal of Neuroinflammation
- Unknown
- (2012) Sangeeta Chavan et al. MOLECULAR MEDICINE
- Unknown
- (2012) Huan Yang et al. MOLECULAR MEDICINE
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
- (2011) Ulf Andersson et al. Annual Review of Immunology
- Unknown
- (2011) Hanna Schierbeck et al. MOLECULAR MEDICINE
- A Monoclonal Antibody Against RAGE Alters Gene Expression and is Protective in Experimental Models of Sepsis and Pneumococcal Pneumonia
- (2011) Eirini Christaki et al. SHOCK
- Anti-HMGB1 Neutralization Antibody Improves Pain-Related Behavior Induced by Application of Autologous Nucleus Pulposus Onto Nerve Roots in Rats
- (2011) Ken-ichi Otoshi et al. SPINE
- Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in Rats
- (2011) Jiyong Zhang et al. STROKE
- TLR4 Mediates Early Graft Failure After Intraportal Islet Transplantation
- (2010) Q. Gao et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice
- (2010) Konstantin Tsoyi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro
- (2010) Yan Ling et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Preconditioning With High Mobility Group Box 1 (HMGB1) Induces Lipoteichoic Acid (LTA) Tolerance
- (2010) Stephen M. Robert et al. JOURNAL OF IMMUNOTHERAPY
- A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
- (2010) H. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting HMGB1 in inflammation
- (2009) Huan Yang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Protective Effect of HMGB1 A Box on Organ Injury of Acute Pancreatitis in Mice
- (2009) Hai Yuan et al. PANCREAS
- Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin-Thrombomodulin Complexes
- (2008) Takashi Ito et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
- (2008) Martin Andrassy et al. CIRCULATION
- Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance
- (2008) Rajesh K. Aneja et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
- (2008) S. Muhammad et al. JOURNAL OF NEUROSCIENCE
- Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia
- (2008) M. Rosas-Ballina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective Effect of Antagonist of High-mobility Group Box 1 on Lipopolysaccharide-Induced Acute Lung Injury in Mice
- (2008) Q. Gong et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now